AdvaStim Inc., a developer of advanced technology platforms for neuromodulation therapies, received a patent by the United States Patent and Trademark Office titled "U.S. 8,948,880 B2 Integrated switching circuit and pulse generator in a neurostimulator lead." This new patent expands the company's AdvaStim’s 2014 patent for a neurostimulator/lead system.
“This important new patent further strengthens our intellectual property portfolio at the technological frontier of neurostimulation,” said Laurence Derose, CEO and co-founder of AdvaStim. “This can potentially open up new avenues and approaches for targeted neurostimulation therapies.”
“Integrating the pulse generator circuitry with a dense array of electrodes in a single compact lead can improve power efficiency and potentially improve the reliability of an implantable neurostimulator device,” said Barry Yomtov, chief technology officer and co-founder. “This technology can also provide neurostimulation therapy developers with enhanced flexibility to position devices where needed within the body and help further the next generation of therapy options.”
AdvaStim is addressing neurostimulation market with a hardware/software technology platform to help emerging device companies implement the next generation of implantable device therapeutics. AdvaStim’s ASICore technology is, according to the company, "a state-of-the-art, VLSI (very-large-scale integration)-based chip architecture providing groundbreaking capabilities for multi-channel switching and electrode programming, all adaptable to the industry’s shrinking form factors." AdvaStim’s ASIControl embedded software gives therapy developers complete customization of output parameters for advanced waveform modes.